Daily Stock Analysis, EDIT, Editas Medicine Inc, priceseries

Editas Medicine Inc. Daily Stock Analysis
Stock Information
Open
33.01
Close
32.02
High
33.21
Low
31.36
Previous Close
32.78
Daily Price Gain
-0.76
YTD High
34.37
YTD High Date
Jan 15, 2020
YTD Low
28.11
YTD Low Date
Jan 6, 2020
YTD Price Change
2.58
YTD Gain
8.76%
52 Week High
34.37
52 Week High Date
Jan 15, 2020
52 Week Low
19.00
52 Week Low Date
Feb 7, 2019
52 Week Price Change
5.81
52 Week Gain
22.17%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 14. 2017
18.86
Feb 27. 2017
23.16
8 Trading Days
22.79%
Link
LONG
Jun 16. 2017
16.28
Jun 29. 2017
17.26
9 Trading Days
6.02%
Link
LONG
Nov 15. 2017
24.34
Dec 5. 2017
27.53
13 Trading Days
13.09%
Link
LONG
Dec 21. 2017
26.71
Jan 8. 2018
29.47
10 Trading Days
10.33%
Link
LONG
May 4. 2018
33.00
May 18. 2018
35.51
10 Trading Days
7.61%
Link
LONG
Mar 28. 2019
23.63
Apr 11. 2019
25.54
10 Trading Days
8.08%
Link
LONG
Nov 12. 2019
22.32
Dec 11. 2019
29.71
20 Trading Days
33.13%
Link
Company Information
Stock Symbol
EDIT
Exchange
NasdaqGS
Company URL
http://www.editasmedicine.com
Company Phone
617-401-9000
CEO
Katrine S. Bosley
Headquarters
Massachusetts
Business Address
11 HURLEY ST., CAMBRIDGE, MA 02141
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001650664
About

Editas Medicine, Inc. engages in the development and commercialization of genome editting technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.^ ^ ^

Description

Developing gene editing therapies based on CRISPR/Cas9 technology.